``In the future, this research could have applications in drug development for hormone-dependent cancers, including breast, prostate and endometrial cancers,`` said Chadli.
``One of the major areas of scientific emphasis of the GRU Cancer Center is to develop therapeutic approaches to cancer targeting specific molecules within the cancer cell, including chaperones,`` said Dr Samir N Khleif, Director of the GRU Cancer Center.